SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: wlheatmoon who wrote (2911)6/11/1998 5:11:00 PM
From: jpbrody  Read Replies (1) | Respond to of 5736
 
This is from a Hambrecht & Quist Report on SpectRx (available at spectrx.com )

SpectRx receives an average of approximately $2.00 for each disposable. With a potential U.S. market of 6 million tests per year, the disposable product addresses a potential market of $15 million. The measurement instrument should sell to the end-user for around $4,000 and make up the bulk of revenues for at least a few years. Prices to SpectRx should be higher in Europe. In the United States, this product will save significant costs for the home-health providers who see most jaundiced infants, because they will eliminate the multiple visits required by the slower laboratory-based methods used today.

H & Q is about the least biased I've seen in this whole mess. I'd say that even if CCSI can get 100% of the US market, they are looking at only $15 million/year of revenues.

In my opinion, if they really had confidence in their business plan, they would just ignore Asensio and use this opportunity to buy more. Remember, buyers want the price to be low. Sellers want the price to be high.



To: wlheatmoon who wrote (2911)6/11/1998 5:25:00 PM
From: Mama Bear  Read Replies (2) | Respond to of 5736
 
>>>They have announced on numerous occasion that they're in the FINAL STAGES of negotiation.<<<

Yes, that's one of the biggest red flags, IMO. You should always be careful when a company dangles a nice juicy carrot just out of your reach, and repeatedly moves it out of your grasp. The likelihood after a certain amount of time has passed is that you just aren't going to get a bite. Enough time has passed now to make that judgement.

Barb